Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT00330577
NCT00330577CompletedPhase 4

24-Hour Intraocular Pressure (IOP) And Blood Pressure Control In Glaucoma And Ocular Hypertension Patients

Aristotle University Of Thessaloniki1 site in 1 country30 target enrollmentStarted: April 1, 2006Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions
Drugs

Trial Snapshot

Phase
Phase 4
Status
Completed
Enrollment
30
Locations
1
Study OverviewStudy DesignEligibility CriteriaInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

The purpose of this study is to compare the short-term mean 24-hour intraocular pressure control, 24-hour blood pressure effect and safety of Latanoprost/Timolol fixed combination given once in the evening with placebo once in the morning versus timolol maleate 0.5% given twice daily in patients with ocular hypertension and primary open-angle glaucoma.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Treatment
Masking
Double

Eligibility Criteria

Ages
29 Years to 80 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • •Advanced glaucoma
  • •Arterial Hypertension

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

AGP Konstas

Professor in Ophthalmology

Aristotle University Of Thessaloniki

Study Sites (1)

Loading locations...

Similar Trials

Completed
Phase 3
24-Hour Intraocular Pressure (IOP) Control With Travoprost/Timolol Fixed CombinationPrimary Open Angle GlaucomaExfoliation Syndrome
NCT00331240Aristotle University Of Thessaloniki32
Completed
Phase 4
24-Hour Intraocular Pressure Control With Bimatoprost/Timolol Versus Latanoprost as First ChoiceGlaucoma
NCT01448837Aristotle University Of Thessaloniki37
Completed
Phase 4
24-hour Control of Intraocular Pressure (IOP) in Ocular HypertensionOcular Hypertension
NCT01655758University of Parma61
Completed
Not Applicable
IOP Device Comparison StudyIntraocular Pressure
NCT04211792Lawson Health Research Institute101
Terminated
Not Applicable
Intraocular Pressure (IOP) Patterns in Fast Versus Slow Visual Field (VF) Progression PatientsPrimary Open-angle Glaucoma (POAG) Patient
NCT01828255Sensimed AG40